(Q84083027)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

chronic renal insufficiency

31 January 2020

main subject

1 reference

Michael van Husen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ann-Katrin Fischer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Anja Lehnhardt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ilka Klaassen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kristina Möller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Dirk-E Müller-Wiefel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Markus J Kemper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

21 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

200-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20407479%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2010.107

31 January 2020

exact match

0 references

cites work

The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Novel regulators of phosphate homeostasis and bone metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

How fibroblast growth factor 23 works

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Does FGF23 toxicity influence the outcome of chronic kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

The bone-renal axis in early chronic kidney disease: an emerging paradigm

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

FGF-23 in dialysis patients: ready for prime time?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.107

1 reference

7 January 2021

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Regulation of fibroblast growth factor-23 in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Vitamin D insufficiency and deficiency in children with early chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.107

7 January 2021